Dr. Roy Davis provides an overview of the current challenges of sepsis diagnosis and management, specifically related to early identification and appropriate intervention. He describes how the host immune response can be leveraged by including a gene expression assay as part of the Sepsis Clinical Toolset. The proposed role for this assay in the clinical workflow and sepsis program triage is covered along with its impact on diagnostic uncertainty.

свернуть